+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Urinary Catheters Market Report and Forecast 2023-2031

  • PDF Icon


  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797984
The global urinary catheters market value in 2022 was USD 1.94 billion, driven by the increasing prevalence of urinary disorders across the globe. The market size is anticipated to grow at a CAGR of 4% during the forecast period of 2023-2031 to achieve a value of USD 2.76 billion by 2031.

Urinary Catheters Introduction

Urinary catheters are medical devices used to drain urine from the bladder when a patient is unable to empty it naturally. They are typically made of flexible materials like rubber, silicone, or latex and come in various types, such as indwelling (Foley) catheters, intermittent (short-term) catheters, and external (condom) catheters. Urinary catheters are used in a variety of medical settings, including hospitals, long-term care facilities, and home care, for patients with urinary incontinence, urinary retention, or postoperative care needs.

Urinary Catheters Market Scenario

The global urinary catheters market has experienced significant growth in recent years, driven by factors such as an aging global population, increasing prevalence of urinary disorders, advancements in catheter materials and designs, and growing awareness about the importance of proper urinary care.

North America: The largest market for urinary catheters, driven by factors such as the advanced healthcare infrastructure, a high prevalence of urinary disorders, and the presence of major urinary catheter manufacturers.

Europe: The second-largest market, with increasing demand for urinary catheters due to a growing aging population and a supportive regulatory framework.

Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure.

Urinary Catheters Market Segmentations

Market Breakup by Product Type

  • Intermittent Catheters
  • Foley/ Indwelling Catheters
  • External Catheters

Market Breakup by Type

  • Coated Catheters
  • Uncoated Catheters

Market Breakup by Applications

  • Benign Prostate Hyperplasia & Prostate Surgeries
  • Urinary Incontinence (UI)
  • Spinal Cord Injury
  • Others

Market Breakup by Gender

  • Male Catheters
  • Female Catheters

Market Breakup by End User

  • Long Term Care Facilities
  • Hospitals
  • Clinics
  • Community healthcare
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the Urinary Catheters Market

Some key trends in the urinary catheters market are:
  • Growing aging population: The aging population is expected to drive the demand for urinary catheters as elderly individuals are more prone to urinary incontinence and related issues
  • Technological advancements: The introduction of innovative urinary catheters with improved design and features, such as hydrophilic coatings, antimicrobial materials, and self-lubricating materials, is expected to increase the demand for such products
  • Increasing prevalence of urologic disorders: The rising incidence of urologic disorders, such as urinary incontinence, bladder dysfunction, and neurogenic bladder, is expected to boost the demand for urinary catheters
  • Growing healthcare expenditure: The increasing healthcare expenditure across the globe is expected to drive the demand for urinary catheters as healthcare facilities are likely to invest in advanced medical devices to provide better patient care
  • Favourable reimbursement policies: The availability of favourable reimbursement policies for urinary catheters is expected to boost the demand for these products, especially in the developing countries, where the cost of medical devices is a major concern for patients

Urinary Catheters Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Coloplast
  • B. Braun Melsungen AG
  • BD
  • Hollister Incorporated
  • Medtronic
  • Teleflex Incorporated
  • ConvaTec Group PLC
  • Rocamed
  • Dentsply Sirona
  • Boston Scientific Corporation
  • Bactiguard AB
  • Amsino International, Inc
  • Well Lead Medical Co.,Ltd
  • Zhanjiang Star Enterprise Co., Ltd
  • Guangdong Haiou Medical Apparatus Co., Ltd
  • Henan Shuguang Jianshi Medical Equipment Group Co., Ltd
  • Urocare Products, Inc
  • Degania Silicone Ltd

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Urinary Catheters Market Overview
3.1 Global Urinary Catheters Market Historical Value (2016-2022)
3.2 Global Urinary Catheters Market Forecast Value (2023-2031)
4 Global Urinary Catheters Market Landscape
4.1 Global Urinary Catheters Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Urinary Catheters Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by End User
4.2.3 Analysis by Applications
5 Global Urinary Catheters Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Urinary Catheters Market Segmentation
6.1 Global Urinary Catheters Market by Product Type
6.1.1 Market Overview
6.1.2 Intermittent Catheters
6.1.3 Foley/ Indwelling Catheters
6.1.4 External Catheters
6.2 Global Urinary Catheters Market by Type
6.2.1 Market Overview
6.2.2 Coated Catheters
6.2.3 Uncoated Catheters
6.3 Global Urinary Catheters Market by Applications
6.3.1 Market Overview
6.3.2 Benign Prostate Hyperplasia & Prostate Surgeries
6.3.3 Urinary Incontinence (UI)
6.3.4 Spinal Cord Injury
6.3.5 Others
6.4 Global Urinary Catheters Market by Gender
6.4.1 Market Overview
6.4.2 Male Catheters
6.4.3 Female Catheters
6.5 Global Urinary Catheters Market by End User
6.5.1 Market Overview
6.5.2 Long Term Care Facilities
6.5.3 Hospitals
6.5.4 Clinics
6.5.5 Community healthcare
6.5.6 Others
6.6 Global Urinary Catheters Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Urinary Catheters Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Urinary Catheters Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Urinary Catheters Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Urinary Catheters Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Urinary Catheters Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Coloplast
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 B. Braun Melsungen AG
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 BD
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Hollister Incorporated
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Medtronic
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Teleflex Incorporated
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 ConvaTec Group PLC
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Rocamed
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Dentsply Sirona
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Boston Scientific Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Bactiguard AB
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Amsino International, Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Well Lead Medical Co.,Ltd.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Zhanjiang Star Enterprise Co., Ltd.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Guangdong Haiou Medical Apparatus Co., Ltd
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Henan Shuguang Jianshi Medical Equipment Group Co., Ltd
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 Urocare Products, Inc.
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
17.19 Degania Silicone Ltd.
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisitions
17.19.5 Certifications
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisitions
17.20.5 Certifications
18 Global Urinary Catheters Market-Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Pricing Models and Strategies (Additional Insight)
21.1 Overview
21.2 Cost Model
21.2.1 Manufacturing Cost Analysis
21.2.2 Procurement Cost Analysis
21.2.3 Clinical Trial Cost Factors
21.3 Pricing Strategies
21.3.1 Competitor Pricing Analysis
21.3.2 Key Assessment of Product Attributes
21.3.3 Pricing Benchmark

Companies Mentioned

  • Coloplast
  • B. Braun Melsungen AG
  • Bd
  • Hollister Incorporated
  • Medtronic
  • Teleflex Incorporated
  • Convatec Group plc
  • Rocamed
  • Dentsply Sirona
  • Boston Scientific Corporation
  • Bactiguard Ab
  • Pacific Hospital Supply Co. Ltd.
  • Amsino International, Inc.
  • Well Lead Medical Co.Ltd.
  • Zhanjiang Star Enterprise Co. Ltd.
  • Guangdong Haiou Medical Apparatus Co. Ltd
  • Henan Shuguang Jianshi Medical Equipment Group Co. Ltd
  • Urocare Products, Inc.
  • Degania Silicone Ltd.
  • Cure Medical, LLC



Table Information